Duopharma Biotech Berhad (KLSE:DPHARMA)
1.330
-0.050 (-3.62%)
At close: Feb 6, 2026
Duopharma Biotech Berhad Revenue
Duopharma Biotech Berhad had revenue of 222.49M MYR in the quarter ending September 30, 2025, with 6.59% growth. This brings the company's revenue in the last twelve months to 900.68M, up 14.37% year-over-year. In the year 2024, Duopharma Biotech Berhad had annual revenue of 813.70M with 15.46% growth.
Revenue (ttm)
900.68M
Revenue Growth
+14.37%
P/S Ratio
1.42
Revenue / Employee
460.23K
Employees
1,957
Market Cap
1.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 813.70M | 108.97M | 15.46% |
| Dec 31, 2023 | 704.73M | 8.01M | 1.15% |
| Dec 31, 2022 | 696.72M | 57.54M | 9.00% |
| Dec 31, 2021 | 639.18M | 69.27M | 12.16% |
| Dec 31, 2020 | 569.90M | -6.56M | -1.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DXN Holdings Bhd. | 1.91B |
| Y.S.P. Southeast Asia Holding Berhad | 367.14M |
| Kotra Industries Berhad | 223.64M |
| Rhone Ma Holdings Berhad | 211.93M |
| PeterLabs Holdings Berhad | 152.65M |
| Sunzen Group Berhad | 77.29M |
| Nova Wellness Group Berhad | 45.99M |
| Bioalpha Holdings Berhad | 5.14M |